Imatinib Mesylate Tablets Market, Global Outlook and Forecast 2022-2028

April 2022 | 60 pages | ID: IC5358C55D34EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Imatinib Mesylate Tablets in Global, including the following market information:

Global Imatinib Mesylate Tablets Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Imatinib Mesylate Tablets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

100 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Imatinib Mesylate Tablets include Teva Pharmaceuticals, Hikma Pharmaceuticals, Apotex Inc, Sun Pharmaceutical Industries, Lupin Limited, Natco Pharma and Getwell Oncology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Imatinib Mesylate Tablets companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Imatinib Mesylate Tablets Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Imatinib Mesylate Tablets Market Segment Percentages, by Type, 2021 (%)

• 100 mg
• 400 mg

Global Imatinib Mesylate Tablets Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Imatinib Mesylate Tablets Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics

Global Imatinib Mesylate Tablets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Imatinib Mesylate Tablets Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Imatinib Mesylate Tablets revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Imatinib Mesylate Tablets revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva Pharmaceuticals
• Hikma Pharmaceuticals
• Apotex Inc
• Sun Pharmaceutical Industries
• Lupin Limited
• Natco Pharma
• Getwell Oncology

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Imatinib Mesylate Tablets Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Imatinib Mesylate Tablets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IMATINIB MESYLATE TABLETS OVERALL MARKET SIZE

2.1 Global Imatinib Mesylate Tablets Market Size: 2021 VS 2028
2.2 Global Imatinib Mesylate Tablets Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Imatinib Mesylate Tablets Players in Global Market
3.2 Top Global Imatinib Mesylate Tablets Companies Ranked by Revenue
3.3 Global Imatinib Mesylate Tablets Revenue by Companies
3.4 Top 3 and Top 5 Imatinib Mesylate Tablets Companies in Global Market, by Revenue in 2021
3.5 Global Companies Imatinib Mesylate Tablets Product Type
3.6 Tier 1, Tier 2 and Tier 3 Imatinib Mesylate Tablets Players in Global Market
  3.6.1 List of Global Tier 1 Imatinib Mesylate Tablets Companies
  3.6.2 List of Global Tier 2 and Tier 3 Imatinib Mesylate Tablets Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Imatinib Mesylate Tablets Market Size Markets, 2021 & 2028
  4.1.2 100 mg
  4.1.3 400 mg
4.2 By Type - Global Imatinib Mesylate Tablets Revenue & Forecasts
  4.2.1 By Type - Global Imatinib Mesylate Tablets Revenue, 2017-2022
  4.2.2 By Type - Global Imatinib Mesylate Tablets Revenue, 2023-2028
  4.2.3 By Type - Global Imatinib Mesylate Tablets Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Imatinib Mesylate Tablets Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinics
5.2 By Application - Global Imatinib Mesylate Tablets Revenue & Forecasts
  5.2.1 By Application - Global Imatinib Mesylate Tablets Revenue, 2017-2022
  5.2.2 By Application - Global Imatinib Mesylate Tablets Revenue, 2023-2028
  5.2.3 By Application - Global Imatinib Mesylate Tablets Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Imatinib Mesylate Tablets Market Size, 2021 & 2028
6.2 By Region - Global Imatinib Mesylate Tablets Revenue & Forecasts
  6.2.1 By Region - Global Imatinib Mesylate Tablets Revenue, 2017-2022
  6.2.2 By Region - Global Imatinib Mesylate Tablets Revenue, 2023-2028
  6.2.3 By Region - Global Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Imatinib Mesylate Tablets Revenue, 2017-2028
  6.3.2 US Imatinib Mesylate Tablets Market Size, 2017-2028
  6.3.3 Canada Imatinib Mesylate Tablets Market Size, 2017-2028
  6.3.4 Mexico Imatinib Mesylate Tablets Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Imatinib Mesylate Tablets Revenue, 2017-2028
  6.4.2 Germany Imatinib Mesylate Tablets Market Size, 2017-2028
  6.4.3 France Imatinib Mesylate Tablets Market Size, 2017-2028
  6.4.4 U.K. Imatinib Mesylate Tablets Market Size, 2017-2028
  6.4.5 Italy Imatinib Mesylate Tablets Market Size, 2017-2028
  6.4.6 Russia Imatinib Mesylate Tablets Market Size, 2017-2028
  6.4.7 Nordic Countries Imatinib Mesylate Tablets Market Size, 2017-2028
  6.4.8 Benelux Imatinib Mesylate Tablets Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Imatinib Mesylate Tablets Revenue, 2017-2028
  6.5.2 China Imatinib Mesylate Tablets Market Size, 2017-2028
  6.5.3 Japan Imatinib Mesylate Tablets Market Size, 2017-2028
  6.5.4 South Korea Imatinib Mesylate Tablets Market Size, 2017-2028
  6.5.5 Southeast Asia Imatinib Mesylate Tablets Market Size, 2017-2028
  6.5.6 India Imatinib Mesylate Tablets Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Imatinib Mesylate Tablets Revenue, 2017-2028
  6.6.2 Brazil Imatinib Mesylate Tablets Market Size, 2017-2028
  6.6.3 Argentina Imatinib Mesylate Tablets Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Imatinib Mesylate Tablets Revenue, 2017-2028
  6.7.2 Turkey Imatinib Mesylate Tablets Market Size, 2017-2028
  6.7.3 Israel Imatinib Mesylate Tablets Market Size, 2017-2028
  6.7.4 Saudi Arabia Imatinib Mesylate Tablets Market Size, 2017-2028
  6.7.5 UAE Imatinib Mesylate Tablets Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Teva Pharmaceuticals
  7.1.1 Teva Pharmaceuticals Corporate Summary
  7.1.2 Teva Pharmaceuticals Business Overview
  7.1.3 Teva Pharmaceuticals Imatinib Mesylate Tablets Major Product Offerings
  7.1.4 Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue in Global Market (2017-2022)
  7.1.5 Teva Pharmaceuticals Key News
7.2 Hikma Pharmaceuticals
  7.2.1 Hikma Pharmaceuticals Corporate Summary
  7.2.2 Hikma Pharmaceuticals Business Overview
  7.2.3 Hikma Pharmaceuticals Imatinib Mesylate Tablets Major Product Offerings
  7.2.4 Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue in Global Market (2017-2022)
  7.2.5 Hikma Pharmaceuticals Key News
7.3 Apotex Inc
  7.3.1 Apotex Inc Corporate Summary
  7.3.2 Apotex Inc Business Overview
  7.3.3 Apotex Inc Imatinib Mesylate Tablets Major Product Offerings
  7.3.4 Apotex Inc Imatinib Mesylate Tablets Revenue in Global Market (2017-2022)
  7.3.5 Apotex Inc Key News
7.4 Sun Pharmaceutical Industries
  7.4.1 Sun Pharmaceutical Industries Corporate Summary
  7.4.2 Sun Pharmaceutical Industries Business Overview
  7.4.3 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Major Product Offerings
  7.4.4 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue in Global Market (2017-2022)
  7.4.5 Sun Pharmaceutical Industries Key News
7.5 Lupin Limited
  7.5.1 Lupin Limited Corporate Summary
  7.5.2 Lupin Limited Business Overview
  7.5.3 Lupin Limited Imatinib Mesylate Tablets Major Product Offerings
  7.5.4 Lupin Limited Imatinib Mesylate Tablets Revenue in Global Market (2017-2022)
  7.5.5 Lupin Limited Key News
7.6 Natco Pharma
  7.6.1 Natco Pharma Corporate Summary
  7.6.2 Natco Pharma Business Overview
  7.6.3 Natco Pharma Imatinib Mesylate Tablets Major Product Offerings
  7.6.4 Natco Pharma Imatinib Mesylate Tablets Revenue in Global Market (2017-2022)
  7.6.5 Natco Pharma Key News
7.7 Getwell Oncology
  7.7.1 Getwell Oncology Corporate Summary
  7.7.2 Getwell Oncology Business Overview
  7.7.3 Getwell Oncology Imatinib Mesylate Tablets Major Product Offerings
  7.7.4 Getwell Oncology Imatinib Mesylate Tablets Revenue in Global Market (2017-2022)
  7.7.5 Getwell Oncology Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Imatinib Mesylate Tablets Market Opportunities & Trends in Global Market
Table 2. Imatinib Mesylate Tablets Market Drivers in Global Market
Table 3. Imatinib Mesylate Tablets Market Restraints in Global Market
Table 4. Key Players of Imatinib Mesylate Tablets in Global Market
Table 5. Top Imatinib Mesylate Tablets Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Imatinib Mesylate Tablets Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Imatinib Mesylate Tablets Revenue Share by Companies, 2017-2022
Table 8. Global Companies Imatinib Mesylate Tablets Product Type
Table 9. List of Global Tier 1 Imatinib Mesylate Tablets Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Imatinib Mesylate Tablets Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Imatinib Mesylate Tablets Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Imatinib Mesylate Tablets Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Imatinib Mesylate Tablets Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Imatinib Mesylate Tablets Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Imatinib Mesylate Tablets Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Imatinib Mesylate Tablets Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Imatinib Mesylate Tablets Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Imatinib Mesylate Tablets Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Imatinib Mesylate Tablets Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Imatinib Mesylate Tablets Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Imatinib Mesylate Tablets Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Imatinib Mesylate Tablets Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Imatinib Mesylate Tablets Revenue, (US$, Mn), 2023-2028
Table 30. Teva Pharmaceuticals Corporate Summary
Table 31. Teva Pharmaceuticals Imatinib Mesylate Tablets Product Offerings
Table 32. Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue (US$, Mn), (2017-2022)
Table 33. Hikma Pharmaceuticals Corporate Summary
Table 34. Hikma Pharmaceuticals Imatinib Mesylate Tablets Product Offerings
Table 35. Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue (US$, Mn), (2017-2022)
Table 36. Apotex Inc Corporate Summary
Table 37. Apotex Inc Imatinib Mesylate Tablets Product Offerings
Table 38. Apotex Inc Imatinib Mesylate Tablets Revenue (US$, Mn), (2017-2022)
Table 39. Sun Pharmaceutical Industries Corporate Summary
Table 40. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Product Offerings
Table 41. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue (US$, Mn), (2017-2022)
Table 42. Lupin Limited Corporate Summary
Table 43. Lupin Limited Imatinib Mesylate Tablets Product Offerings
Table 44. Lupin Limited Imatinib Mesylate Tablets Revenue (US$, Mn), (2017-2022)
Table 45. Natco Pharma Corporate Summary
Table 46. Natco Pharma Imatinib Mesylate Tablets Product Offerings
Table 47. Natco Pharma Imatinib Mesylate Tablets Revenue (US$, Mn), (2017-2022)
Table 48. Getwell Oncology Corporate Summary
Table 49. Getwell Oncology Imatinib Mesylate Tablets Product Offerings
Table 50. Getwell Oncology Imatinib Mesylate Tablets Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Imatinib Mesylate Tablets Segment by Type in 2021
Figure 2. Imatinib Mesylate Tablets Segment by Application in 2021
Figure 3. Global Imatinib Mesylate Tablets Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Imatinib Mesylate Tablets Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Imatinib Mesylate Tablets Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Imatinib Mesylate Tablets Revenue in 2021
Figure 8. By Type - Global Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
Figure 9. By Application - Global Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
Figure 10. By Region - Global Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
Figure 11. By Country - North America Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
Figure 12. US Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
Figure 16. Germany Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 17. France Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
Figure 24. China Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 28. India Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
Figure 30. Brazil Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
Figure 33. Turkey Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 37. Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Apotex Inc Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Lupin Limited Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Natco Pharma Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Getwell Oncology Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)